Jenner & Block

 

Among Mr. Casella’s representative engagements:

  • Snyder’s-Lance Inc. in its $6.1 billion sale to Campbell Soup Company;
  • US Foods Holding Corp. in its $1.175 billion initial public offering;
  • US Foods Holding Corp. in a $1.0 billion secondary offering of common stock;
  • Snyder’s-Lance Inc. in its $1.8 billion acquisition of Diamond Foods Inc.;
  • Hertz Global Holdings, Inc. in the $2.0 billion spinoff of its equipment rental business;
  • Obagi Medical Products in its $420 million sale to Valeant Pharmaceuticals;
  • NPS Pharmaceuticals, Inc. in its $100 million public offering of common stock;
  • Heartland Payment Systems, Inc. in its initial public offering and secondary offering of common stock, and various acquisitions and investments;
  • Otsuka Pharmaceutical in its acquisition of PDL BioPharma Inc.’s rights to IV Busulfex and its acquisition of all outstanding stock of Interpharma Praha, a.s.;
  • Enzon Pharmaceuticals in its sale of a portion of its royalty interest for PEG- Intron;
  • Tengion, Inc., a leader in the field of regenerative medicine, in its initial public offering;
  • Obagi Medical Products in its public offering and secondary offering of common stock;
  • Panther Trucking in its sale to private equity firm Fenway Partners;
  • Hemmings Motor News in its sale to American City Business Journals;
  • A.L. Industrier AS, the controlling shareholder of Alpharma, Inc., in its sale of its interest in Alpharma;
  • Mudd (USA) LLC in the sale of substantially all of its assets related to the Mudd brand of pre-teen and junior girls’ clothing to Iconix Brand Group, Inc.; and
  • Petters Group Worldwide, an investment company, in its acquisition of Polaroid Holding Company, a developer and manufacturer of instant and digital imaging products.